AnaptysBio’s drug candidates rosnilimab and ANB032 hold key trial results ahead. Find out why ANAB stock is impacted by ...

Concerto Biosciences has dosed the first subject in a Phase I trial of the three-stain live biotherapeutic product, ENS-002, ...

The company has shown significant progress with its lead asset, soquelitinib, particularly in treating atopic dermatitis (AtD). The upcoming interim Phase 1 data, expected in December, has generated ...

I would like to remind everyone that comments made by management today and answers to questions ... and a Phase I trial for ...

About SciBase SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing CohortInterim Data from Atopic Dermatitis Trial ...

SciBase is excited to announce a new collaboration aimed at revolutionizing early detection of atopic diseases in infants through the use of Electrical Impedance Spectroscopy (EIS) technology. This ...

The new Contact Allergen Management Program (CAMP) 2.0, from the American Contact Dermatitis Society (ACDS), is a web- and ...

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

The research aims to develop standardized diagnosis and treatment protocols for atopic dermatitis ... on improving disease understanding and management through medical education.

We have listed some tips and tricks for managing files and folders in Windows 11/10. If you know them, you will better organize file and folder hierarchy. The easiest way to move folders from one ...